TPH1 and neoplasm: platelet-secreted metabolites including tryptophan hydroxylase 1 (TPH1) and prostaglandin E2 (PGE2) synergistically enhance tumor PD-L1 expression through STAT3/NF-κB signaling activation, while pharmacological inhibition of these pathways enhances immune cell infiltration [58, 59].